• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Obstetrics

Different gestational diabetes screening methods cause no difference for complications

byAvneesh BhanguandHarsh Shah
March 10, 2021
in Obstetrics, Pediatrics
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. The one-step screening method increased the incidence of diagnosis compared to the two-step screening method for gestational diabetes.

2. No significant difference was found between the two screening methods for risk of adverse perinatal outcomes, gestational hypertension, and preeclampsia.

Evidence Rating Level: 1 (Excellent)

Study Rundown: There is a lack of consensus on how best to screen gestational diabetes. Currently, the two acceptable screening options include the one-step approach or the two-step approach. This study compared the one-step approach to the two-step approach in two health systems with respect to maternal and neonatal outcomes. This trial found the one-step screening method increased the incidence of gestational diabetes diagnosis compared to the two-step approach. However, there was no additional risk of adverse perinatal outcomes, gestational hypertension, preeclampsia, primary caesarian section, or large-for-gestational age infants between the two approaches. Study limitations include a lack of participant adherence to the one-step approach, and sites using different thresholds for the initial test in the two-step approach. Nonetheless, this study’s results are significant and demonstrate a pragmatic comparison between two common screening methods for gestational diabetes.

Click to read the study in the NEJM (New England Journal of Medicine)

Relevant Reading: Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes – 2020

RELATED REPORTS

Intermittent metformin (Glucophage) is non-inferior to continuous metformin for prediabetes in post-partum women with prior gestational diabetes mellitus

Adverse pregnancy outcomes is associated with worse offspring cardiovascular health in early adulthood

FDA approvedFor hypertension: Baxfendy (baxdrostat), May 15, 2026→

In-Depth [randomized controlled trial]: This randomized controlled trial randomized 23,792 pregnant women receiving care at Kaiser Permanente Northwest and Kaiser Permanente Hawaii. Women 18 years of age or older without pre-existing type 1 or type 2 diabetes were included in the study. Women who had a miscarriage, multiple gestations, or previous bariatric surgery were excluded from the study. Participants were randomized in a 1:1 ratio to either a one-step or two-step screening approach, respectively. Five primary outcomes were defined: 1) diagnosis of gestational diabetes; 2) a composite measure of perinatal outcomes; 3) large-for-gestational age infants; 4) primary caesarian section; and 5) gestational hypertension or preeclampsia. Gestational diabetes was diagnosed in 16.5% of women in the one-step group and 8.5% of women in the two-step group (unadjusted relative risk, 1.94; 97.5% confidence interval [CI], 1.79 to 2.11). No significant difference was found between the two groups with respect to other primary outcomes. These outcomes were a composite measure of perinatal outcomes (one-step group, 3.1%; two-step group, 3.0%; relative risk, 1.04; 97.5% CI, 0.88 to 1.23); primary caesarian section (one-step group, 24%; two-step group, 24.6%; relative risk, 0.98; 97.5% CI, 0.93 to 1.02), and gestational hypertension or preeclampsia (one-step group, 13.6%; two-step group,13.5%; relative risk, 1.00; 97.5% CI, 0.93 to 1.08). Altogether, compared to two-step screening, the one-step screening increased the incidence of diagnosis, but no difference was found in other predefined outcomes.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: gestational diabetesgestational hypertensionperinatal outcomespreeclampsia
Previous Post

Nivolumab and cabozantinib superior to sunitinib for advanced renal-cell carcinoma

Next Post

Whole-genome sequencing more accurate than cytogenetic analysis in myeloid cancers

RelatedReports

Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens
Chronic Disease

Intermittent metformin (Glucophage) is non-inferior to continuous metformin for prediabetes in post-partum women with prior gestational diabetes mellitus

July 21, 2026
Prenatal antidepressant exposure may increase risk of poor motor development
Cardiology

Adverse pregnancy outcomes is associated with worse offspring cardiovascular health in early adulthood

May 18, 2026
Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Prenatal depression and gestational diabetes are associated with increased risk of childhood obesity

February 23, 2026
Diabetes collage: a lidded sugar bowl inside a blue paper circle, with a whole apple and a bunch of leafy greens
Endocrinology

Time-restricted eating and high-intensity interval training may not affect gestational diabetes risk in pregnant individuals

January 13, 2026
Next Post

Whole-genome sequencing more accurate than cytogenetic analysis in myeloid cancers

Combined division of the splenic vein a safe method for distal pancreatectomy

#VisualAbstract: Pyrotinib plus capecitabine improves progression-free survival in HER2⁺ metastatic breast cancer

#VisualAbstract: Pyrotinib plus capecitabine improves progression-free survival in HER2⁺ metastatic breast cancer

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
  • A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.